Top mRNA therapeutics Stocks in United States
Browse the largest United States companies in the world ranked by their Market Capitalization. Global mRNA therapeutics Companies in United States market cap is $355.74B.
30 Oct 2024, 12:18 UTC
Companies: 33
🇺🇸1 |  | $29.74 | -0.03% | 167.92B | 2.98% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸2 |  | $474.16 | -1.48% | 122.19B | 17.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸3 |  | $69.86 | -2.96% | 26.64B | -30.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸4 |  | $125.01 | -0.54% | 11.69B | 30.90% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸5 |  | $42.36 | 2.05% | 6.08B | -17.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸6 |  | $16.00 | 0.00% | 3.30B | 0.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸7 |  | $42.11 | 2.11% | 2.30B | 7.20% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸8 |  | $20.78 | 3.85% | 2.22B | -31.87% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸9 |  | $25.50 | -0.31% | 2.08B | -5.38% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸10 |  | $22.52 | -0.13% | 2.02B | -25.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸11 |  | $20.85 | -0.90% | 1.27B | -1.51% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸12 |  | $9.21 | 0.77% | 1.22B | 40.83% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸13 |  | $18.07 | -0.66% | 1.19B | 81.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸14 |  | $9.05 | 3.31% | 1.04B | 105.68% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸15 |  | $8.52 | 0.12% | 868.38M | 1451.91% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸16 |  | $3.52 | -2.00% | 764.77M | 1492.76% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸17 |  | $21.55 | 4.56% | 575.89M | -31.76% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸18 |  | $2.15 | -1.38% | 401.96M | 25.73% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸19 |  | $3.87 | 1.04% | 316.08M | -61.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸20 |  | $36.73 | -1.45% | 294.26M | -22.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸21 |  | $3.93 | -1.75% | 247.06M | 22.05% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸22 |  | $9.26 | 1.54% | 220.51M | 36.58% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸23 |  | $2.08 | -0.95% | 183.94M | -63.57% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸24 |  | $5.12 | 0.79% | 157.66M | 4.70% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸25 |  | $5.46 | 2.44% | 135.26M | 10.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸26 |  | $0.18 | -11.62% | 56.62M | 28.68% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸27 |  | $3.92 | -2.24% | 40.68M | 284.31% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸28 |  | $0.43 | 2.44% | 37.78M | -90.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸29 |  | $3.66 | -0.95% | 16.74M | 401.37% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸30 |  | $1.04 | -0.95% | 12.85M | 126.09% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸31 |  | $1.41 | -6.62% | 7.63M | -24.60% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸32 |  | $0.21 | -14.88% | 2.27M | -55.22% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
